SCHEMBL5701010

SCHEMBL5701010

COC(=O)/C=C/c1ccc(NC(=O)OC(C)(C)C)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
TYR P14679 1/20 0.55
CA7 P43166 1/20 0.55
CA9 Q16790 1/20 0.55
CA14 Q9ULX7 1/20 0.55
HDAC3 O15379 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC2 Q92769 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
PTPN1 P18031 1/20 0.49
TRPV1 Q8NER1 1/20 0.48
TTR P02766 1/20 0.48
APP P05067 1/20 0.48
CYP17A1 P05093 2/20 0.45
MAPT P10636 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
TP53 P04637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5701011 1.00 CA12 (0.55) CA12CA1CA2TYRCA7
SCHEMBL3025158 0.87 HDAC3 (0.54) CA12CA1CA2TYRCA7
SCHEMBL3025161 0.87 HDAC3 (0.54) CA12CA1CA2TYRCA7
SCHEMBL7748046 0.86 CA12 (0.57) CA12CA1CA2CA7CA9
SCHEMBL15111173 0.86 CA12 (0.57) CA12CA1CA2TYRCA7
SCHEMBL7748042 0.86 CA12 (0.57) CA12CA1CA2CA7CA9
SCHEMBL15111172 0.86 CA12 (0.57) CA12CA1CA2TYRCA7
SCHEMBL596259 0.83 HDAC3 (0.50) CA12CA1CA9HDAC3HDAC1
SCHEMBL596258 0.83 HDAC3 (0.50) CA12CA1CA9HDAC3HDAC1
SCHEMBL10045883 0.83 HDAC3 (0.50) CA12CA1CA9HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1027328-B1 SUBSTITUTED ANILIDES AVENTIS PHARMA LTD (GB) 2006-08-23 EP disclosed
US-6479519-B1 INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE AVENTIS PHARMA LIMITED (GB) 2002-11-12 US disclosed
EP-1027328-A1 SUBSTITUTED ANILIDES Aventis Pharma Limited (GB) 2000-08-16 EP disclosed
WO-1999023063-A1 SUBSTITUTED ANILIDES AVENTIS PHARMA LIMITED (GB) 1999-05-14 WO disclosed